Literature DB >> 17049878

Over-expression in Escherichia coli, purification and characterization of isoform 2 of human FAD synthetase.

Michele Galluccio1, Carmen Brizio, Enza Maria Torchetti, Pasquale Ferranti, Elisabetta Gianazza, Cesare Indiveri, Maria Barile.   

Abstract

FAD synthetase (FADS) (EC 2.7.7.2) is a key enzyme in the metabolic pathway that converts riboflavin into the redox cofactor FAD. The human isoform 2 of FADS (hFADS2), which is the product of FLAD1 gene, was over-expressed in Escherichia coli as a T7-tagged protein and identified by MALDI-TOF MS analysis. Its molecular mass, calculated by SDS-PAGE, was approx. 55 kDa. The expressed protein accounted for more than 40% of the total protein extracted from the cell culture; 10% of it was recovered in a soluble and nearly pure form by Triton X-100 treatment of the insoluble cell fraction. hFADS2 possesses FADS activity and has a strict requirement for MgCl2, as demonstrated in a spectrophotometric assay. The purified recombinant isoform 2 showed a kcat of 3.6 x 10(-3)s(-1) and exhibited a KM value for FMN of about 0.4 microM. The expression of the hFADS2 isoform opens new perspectives in the structural studies of this enzyme and in the design of antibiotics based on the functional differences between the bacterial and the human enzymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049878     DOI: 10.1016/j.pep.2006.09.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  19 in total

1.  Structure and mechanism of a eukaryotic FMN adenylyltransferase.

Authors:  Carlos Huerta; Dominika Borek; Mischa Machius; Nick V Grishin; Hong Zhang
Journal:  J Mol Biol       Date:  2009-04-16       Impact factor: 5.469

Review 2.  Riboflavin transport and metabolism in humans.

Authors:  Maria Barile; Teresa Anna Giancaspero; Piero Leone; Michele Galluccio; Cesare Indiveri
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

3.  Continuous and Discontinuous Approaches to Study FAD Synthesis and Degradation Catalyzed by Purified Recombinant FAD Synthase or Cellular Fractions.

Authors:  Piero Leone; Maria Tolomeo; Maria Barile
Journal:  Methods Mol Biol       Date:  2021

4.  Purification of Recombinant Human 6His-FAD Synthase (Isoform 2) and Quantitation of FAD/Protein Monomer Ratio by UV-Vis Spectra.

Authors:  Piero Leone; Stefano Quarta; Maria Tolomeo; Maria Barile
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Alteration of Flavin Cofactor Homeostasis in Human Neuromuscular Pathologies.

Authors:  Maria Tolomeo; Alessia Nisco; Maria Barile
Journal:  Methods Mol Biol       Date:  2021

6.  The puzzle of ligand binding to Corynebacterium ammoniagenes FAD synthetase.

Authors:  Susana Frago; Adrián Velázquez-Campoy; Milagros Medina
Journal:  J Biol Chem       Date:  2009-01-11       Impact factor: 5.157

7.  Flavin nucleotide metabolism in plants: monofunctional enzymes synthesize fad in plastids.

Authors:  Francisco J Sandoval; Yi Zhang; Sanja Roje
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

8.  FAD synthesis and degradation in the nucleus create a local flavin cofactor pool.

Authors:  Teresa Anna Giancaspero; Giovanni Busco; Concetta Panebianco; Claudia Carmone; Angelica Miccolis; Grazia Maria Liuzzi; Matilde Colella; Maria Barile
Journal:  J Biol Chem       Date:  2013-08-14       Impact factor: 5.157

9.  Bacterial over-expression and purification of the 3'phosphoadenosine 5'phosphosulfate (PAPS) reductase domain of human FAD synthase: functional characterization and homology modeling.

Authors:  Angelica Miccolis; Michele Galluccio; Teresa Anna Giancaspero; Cesare Indiveri; Maria Barile
Journal:  Int J Mol Sci       Date:  2012-12-11       Impact factor: 5.923

10.  Role of key residues at the flavin mononucleotide (FMN):adenylyltransferase catalytic site of the bifunctional riboflavin kinase/flavin adenine dinucleotide (FAD) Synthetase from Corynebacterium ammoniagenes.

Authors:  Ana Serrano; Susana Frago; Adrián Velázquez-Campoy; Milagros Medina
Journal:  Int J Mol Sci       Date:  2012-11-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.